Scott Bader invests £30M to transform
The five-year programme will commence in 2024 with £8M earmarked for the first phase of the works. This planned investment will support the group’s UK customers by making the plant more flexible – enabling quicker lead times and the rapid scaling up of an increasing number of sustainable alternatives to the Group’s current products as well as new performance products in areas such as 3D printing.
This commitment to the UK market will ensure the company’s future key product brands including Crystic resins and gelcoats, Crestabond structural adhesives and Crestapol performance resins. Recent R&D investment – both in the UK and globally – has bolstered Scott Bader’s exploration of more sustainable alternatives and innovations that lead to the ‘lightweighting’ of composite parts for markets such as EV’s, renewable energy and land transportation, as well as the development of bio-based ingredients for the personal care market.
Expansion in France and the USA
Alongside allocating the capital to transform its UK site, the company has also created a €2M laboratory facility in France, which will open in Q1 2024. Outside of Europe, Scott Bader’s two-year build of a $16M new manufacturing facility in Mocksville, USA, also becomes fully operational in 2024. These investments are designed to bring the manufacturer’s enhanced capabilities closer to its global customer base, helping with the longer term goal of shortening supply chains and lowering the carbon footprint associated with transporting goods.